biguanides has been researched along with Alloxan Diabetes in 21 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with diabetes mellitus, dermatophytosis is more severe and recurrent." | 1.72 | Antifungal activity of alexidine dihydrochloride in a novel diabetic mouse model of dermatophytosis. ( Date, A; Ibrahim, AS; Nabeela, S; Uppuluri, P, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (57.14) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Basyouni, WM | 4 |
| Abbas, SY | 4 |
| El-Bayouki, KAM | 2 |
| Younis, EA | 1 |
| Ali, SA | 1 |
| Aly, HF | 3 |
| Nabeela, S | 1 |
| Date, A | 1 |
| Ibrahim, AS | 1 |
| Uppuluri, P | 1 |
| El-Bayouk, KAM | 1 |
| Tohamy, WM | 1 |
| Arafa, A | 2 |
| Soliman, MS | 2 |
| El Shehry, MF | 1 |
| Gupta, D | 1 |
| Thangaraj, D | 1 |
| Radhakrishnan, M | 1 |
| El-Bayouki, KA | 1 |
| Abdel-Rahman, RF | 1 |
| McNamara, DB | 1 |
| Murthy, SN | 1 |
| Fonseca, AN | 1 |
| Desouza, CV | 1 |
| Kadowitz, PJ | 1 |
| Fonseca, VA | 1 |
| Sim, YB | 1 |
| Park, SH | 1 |
| Kang, YJ | 1 |
| Kim, SS | 1 |
| Kim, CH | 1 |
| Kim, SJ | 1 |
| Jung, JS | 1 |
| Ryu, OH | 1 |
| Choi, MG | 1 |
| Suh, HW | 1 |
| McDonald, HJ | 1 |
| DeChatelet, LR | 1 |
| Woo, LC | 1 |
| Yuen, VG | 1 |
| Thompson, KH | 1 |
| McNeill, JH | 1 |
| Orvig, C | 1 |
| Nawar, NN | 1 |
| Kamel, I | 1 |
| Schoukri, NA | 1 |
| Tutwiler, GF | 1 |
| Bridi, G | 1 |
| Losert, W | 2 |
| Loge, O | 2 |
| Schillinger, E | 2 |
| Muntoni, S | 1 |
| Kraaz, W | 1 |
| Jahn, P | 1 |
| Loiseau, G | 1 |
| Millischer, R | 1 |
| Berthe, G | 1 |
| Donadieu, AM | 1 |
| Lohier, P | 1 |
| Marquet, JP | 1 |
| Söling, HD | 2 |
| Moshagen, D | 1 |
| Skutella, E | 1 |
| Kneer, P | 1 |
| Creutzfeldt, W | 1 |
| Förster, O | 1 |
| Rudas, B | 2 |
| Brand, J | 1 |
| Novak, M | 1 |
| Paul, SP | 1 |
3 reviews available for biguanides and Alloxan Diabetes
| Article | Year |
|---|---|
Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic intervention.
Topics: Animals; Biguanides; Catheterization; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Di | 2009 |
Inhibition of fatty acid oxidation by biguanides: implications for metabolic physiopathology.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adipose Tissue; Animals; Biguanides; Biological Trans | 1974 |
[The effects of blood glucose lowering biguanides on liver metabolism].
Topics: Adenosine Triphosphate; Amino Acids; Animals; Biguanides; Diabetes Mellitus, Experimental; Dogs; Glu | 1969 |
18 other studies available for biguanides and Alloxan Diabetes
| Article | Year |
|---|---|
Synthesis and hyperglycemic, biochemical and histopathological evaluation of novel sulfonylbiguanide and sulfonylurea derivatives as potent anti-diabetic agents.
Topics: Animals; Biguanides; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hypoglycemic | 2021 |
Antifungal activity of alexidine dihydrochloride in a novel diabetic mouse model of dermatophytosis.
Topics: Animals; Antifungal Agents; Biguanides; Diabetes Mellitus, Experimental; Disease Models, Animal; Mic | 2022 |
New Biguanides as Anti-Diabetic Agents Part I: Synthesis and Evaluation of 1-Substituted Biguanide Derivatives as Anti-Diabetic Agents of Type II Diabetes Insulin Resistant.
Topics: Animals; Biguanides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hypoglycemic Agents | 2017 |
New Biguanides as Anti-Diabetic Agents, Part II: Synthesis and Anti-Diabetic Properties Evaluation of 1-Arylamidebiguanide Derivatives as Agents of Insulin Resistant Type II Diabetes.
Topics: Administration, Oral; Animals; Biguanides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type | 2017 |
A novel 5HT3 antagonist 4i (N-(3-chloro-2-methylphenyl)quinoxalin-2-carboxamide) prevents diabetes-induced depressive phenotypes in mice: Modulation of serotonergic system.
Topics: Animals; Antidepressive Agents; Biguanides; Brain; Depressive Disorder; Diabetes Mellitus, Experimen | 2016 |
Synthesis and Evaluation of 1-Substituted-Biguanide Derivatives as Anti-Diabetic Agents for Type II Diabetes Insulin Resistant.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biguanides; Blood Glucose; Cholesterol; | 2016 |
Central anti-diabetic action of biguanide and thizolidinediones in D-glucose fed and streptozotocin-treated mouse models.
Topics: Animals; Biguanides; Blood Glucose; Brain; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type | 2012 |
The effects of three oral hypoglycemic agents on the incorporation of leucine-C14 into protein by liver microsomes of normal and alloxan-diabetic rats.
Topics: Animals; Biguanides; Carbon Isotopes; Chlorpropamide; Diabetes Mellitus, Experimental; Female; Leuci | 1967 |
Vanadyl-biguanide complexes as potential synergistic insulin mimics.
Topics: Animals; Biguanides; Blood Glucose; Diabetes Mellitus, Experimental; Drug Synergism; Humans; Hypogly | 1999 |
The histological changes in the diabetic adrenal gland after biguanide induced lactic acidosis.
Topics: Acidosis; Adrenal Glands; Animals; Biguanides; Diabetes Mellitus, Experimental; Lactates; Male; Nerv | 1979 |
Comparison of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective, hypoglycemic agent, with the biguanides.
Topics: Animals; Biguanides; Biological Transport, Active; Blood Glucose; Buformin; Diabetes Mellitus, Exper | 1978 |
[Hypoglycemia induced by N1-(n-butyl)-biguanide (Buformin) in animal experiments].
Topics: Animals; Arabinose; Biguanides; Blood Glucose; Diabetes Mellitus, Experimental; Hypoglycemia; Hypogl | 1969 |
[Studies on the mode of action of biguanides in animals. 4. Studies on gamma-guanidinobutyramide and summary].
Topics: Amides; Animals; Biguanides; Blood Glucose; Butyrates; Carbon Isotopes; Diabetes Mellitus, Experimen | 1972 |
[A phosphorylated biguanide: benfosformin (JAV 852). I. Hypoglycemic and antidiabetic properties].
Topics: Animals; Benzyl Compounds; Biguanides; Blood Glucose; Diabetes Mellitus, Experimental; Hyperglycemia | 1973 |
[The effect of N1, n-butylbiguanide on the metabolism of isolated perfused livers of normal and alloxan-diabetic ketotic rats].
Topics: Amino Acids; Animals; Biguanides; Bile; Depression, Chemical; Diabetes Mellitus, Experimental; Diabe | 1967 |
The uptake of orally administered trioleate- 14 C in normal and diabetic rats with and without butylbiguanide application.
Topics: Adipose Tissue; Administration, Oral; Animals; Biguanides; Carbon Isotopes; Diabetes Mellitus, Exper | 1971 |
The effect of butylbiguanide on the fat-induced hyperlipemia in normal and alloxan diabetic rats.
Topics: Animals; Biguanides; Diabetes Mellitus, Experimental; Fatty Acids, Nonesterified; Glycerides; Glycer | 1970 |
Effects of some synthetic biguanides on certain aspects of carbohydrate metabolism in alloxandiabetic mice.
Topics: Animals; Biguanides; Diabetes Mellitus, Experimental; Epinephrine; Glucose Tolerance Test; Liver Gly | 1966 |